Medicine · 2016 · 21 citations · 10 references
Life SciencesGeneticsOncologyCancer GeneticsMedical GeneticsMolecular OncologyAdrenal TumorsEndocrine Tumor GeneticsGermline Cancer PredispositionGermline Cancer SusceptibilityHereditary Cancer SyndromesMalignant NeoplasmsBeckwith-wiedemann SyndromeBrca MutationsBrca2 InactivationFrameshift MutationsGermline Mutation AnalysisHereditary Endocrine Tumor SyndromesInherited Cancer SusceptibilityLi-fraumeni Syndrome
BACKGROUND: Adrenocortical carcinoma (ACC) may rarely be a component of inherited cancer syndromes such as Li-Fraumeni syndrome and Beckwith-Wiedemann syndrome. ACC caused by a BRCA2 mutation has never been reported. METHODS: Nucleotide sequencing of BRCA2 in lymphocyte and tumoral DNA of a 50-year-old male who presented with an androgen-secreting ACC and a strong family history of breast, ovarian, and pancreatic cancers. RESULTS: A germline BRCA2 2 bp heterozygous deletion at nucleotide 8765 (8765delAG) leading to a frameshift mutation (p.Glu2846GlyfsX23) was detected. Only the BRCA2 deleted allele was retained in the ACC tumoral DNA compared with the control DNA supporting a loss of heterozygosity in the tumor. CONCLUSION: This is the first reported case of a patient with ACC associated with a BRCA2 germline mutation. Loss of heterozygosity in ACC DNA suggests a causal link with the BRCA2 8765delAG mutation.
10
Tobias Else, Alex C. Kim, Aaron Sabolch et al. · Endocrine Reviews · 2013 · 887 citations
Relative frequency and morphology of cancers in carriers of germline TP53 mutations
Jillian M. Birch, Richard McNally, D. Gareth Evans et al. · Oncogene · 2001 · 468 citations
Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
J M Varley, Gail McGown, Mary Thorncroft et al. · PubMed · 1997 · 263 citations